Platelet proteome in healthy volunteers who smoke

Platelets

Volumn 23, Issue 2, 2012, Pages 91-105

  Della Corte, Anna ^a   Tamburrelli, Chiara ^a   Crescente, Marilena ^a   Giordano, Lucia ^a   D'Imperio, Marco ^a   Di Michele, Michela ^a   Donati, Maria Benedetta ^a   De Gaetano, Giovanni ^a   Rotilio, Domenico ^a   Cerletti, Chiara ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

DIGE; factor XIII; mass spectrometry; pathway analysis; platelet proteome; Smoke

Indexed keywords

BETA ACTIN; BLOOD CLOTTING FACTOR 13A; FIBRINOGEN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE ACTIVATION; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SMOKING; TANDEM MASS SPECTROMETRY; THROMBOCYTE; THROMBOCYTE FUNCTION; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; CELL COMMUNICATION; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PROTEOME; PROTEOMICS; SMOKING;

EID: 84856854420     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.587916     Document Type: Article

References (54)

1. Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn HA. Cigarette smoking and coronary heart disease. N Engl J Med 1962;266:796-801.
2. Armani C, Landini Jr L, Leone A. Molecular and biochemical changes of the cardiovascular system due to smoking exposure. Curr Pharm Des 2009;15:1038-1053.
3. Schroeter MR, Sawalich M, Humboldt T, Leifheit M, Meurrens K, Berges A, Xu H, Lebrun S, Wallerath T, Konstantinides S, et al. Cigarette smoke exposure promotes arterial thrombosis and vessel remodeling after vascular injury in apolipoprotein E-deficient mice. J Vasc Res 2008; 45:480-492.
4. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004;43:1731-1737. (Pubitemid 38622506)
5. Petitti DB, Kipp H. The leukocyte count: Associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 1986;123:89-95. (Pubitemid 16189702)
6. Calapai G, Caputi AP, Mannucci C, Gregg EO, Pieratti A, Aurora Russo G, Chaudhary N, Puntoni R, Lowe F, McEwan M, et al. A cross-sectional investigation of bio-markers of risk after a decade of smoking. Inhal Toxicol 2009;21:1138-1143.
7. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: Is it time to intervene? Arterioscler Thromb Vasc Biol 2005;25:658-670. (Pubitemid 40463851)
8. Cerletti C, Evangelista V, de Gaetano G. P-selectin-beta 2-integrin cross-talk: A molecular mechanism for polymor-phonuclear leukocyte recruitment at the site of vascular damage. Thromb Haemost 1999;82:787-793.
9. Glynn MF, Mustard JF, Buchanan MR, Murphy EA. Cigarette smoking and platelet aggregation. Can Med Assoc J 1966;95:549-553.
10. Levine PH. An acute effect of cigarette smoking on platelet function. A possible link between smoking and arterial thrombosis. Circulation 1973;48:619-623.
11. Ring T, Kristensen SD, Jensen PN, Mourits-Andersen T, Madsen H, Dyerberg J. Cigarette smoking shortens the bleeding time. Thromb Res 1983;32:531-536. (Pubitemid 14216150)
12. Fusegawa Y, Goto S, Handa S, Kawada T, Ando Y. Platelet spontaneous aggregation in platelet-rich plasma is increased in habitual smokers. Thromb Res 1999;93:271-278. (Pubitemid 29143551)
13. Nair S, Kulkarni S, Camoens HM, Ghosh K, Mohanty D. Changes in platelet glycoprotein receptors after smoking-a flow cytometric study. Platelets 2001;12:20-26. (Pubitemid 32217569)
14. Neubauer H, Setiadi P, Pinto A, Günesdogan B, Meves SH, Börgel J, Mügge A. Upregulation of platelet CD40, CD40 ligand (CD40L) and P-Selectin expression in cigarette smokers: A flow cytometry study. Blood Coagul Fibrinolysis 2009;20:694-698.
15. Böck M, De Haan J, Beck KH, Gutensohn K, Hertfelder HJ, Karger R, Heim MU, Beeser H, Weber D, Kretschmer V. Standardization of the PFA-100(R) platelet function test in 105 mmol/l buffered citrate: Effect of gender, smoking, and oral contraceptives. Br J Haematol 1999;106:898-904. (Pubitemid 29463001)
16. Jastrzebska M, Chestowski K, Mierzecki A, Klimek K, Bukowska H. Effects of fenofibrate treatment on prothrom-botic state in patients with metabolic syndrome in relation to smoking and diabetes. Med Sci Monit 2009;15:PI27-P133.
17. Garlichs CD, Cicha I, Raaz D, Meyer L, Stumpf C, Klinghammer L, Yilmaz A, Daniel WG. CD40/CD154 system and pro-inflammatory cytokines in young healthy male smokers without additional risk factors for atherosclerosis. Inflamm Res 2009;58:306-311.
18. Banfi C, Brioschi M, Marenzi G, De Metrio M, Camera M, Mussoni L, Tremoli E. Proteome of platelets in patients with coronary artery disease. Exp Hematol 2010;38:341-350.
19. Mateos-Cáceres PJ, Macaya C, Azcona L, Modrego J, Mahillo E, Bernardo E, Fernandez-Ortiz A, López-Farré AJ. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb Haemost 2010;103:160-170.
20. Krishnan S, Gaspari M, Della Corte A, Bianchi P, Crescente M, Cerletti C, Torella D, Indolfi C, de Gaetano G, Donati MB, et al. OFFgel-based multidimensional LC-MS/MS approach to the cataloguing of the human platelet proteome for an interactomic profile. Electrophoresis 2011;32:686-695.
21. Finamore F, Pieroni L, Ronci M, Marzano V, Mortera SL, Romano M, Cortese C, Federici G, Urbani A. Proteomics investigation of human platelets by shogun nUPLC-MSE and 2DE experimental strategies: A comparative study. Blood Transfus 2010;8(Suppl. 3):s140-s148.
22. D'Alessandro A, Righetti PG, Zolla L. The red blood cell proteome and interactome: An update. J Proteome Res 2010;9:144-163.
23. Della Corte A, Maugeri N, Pampuch A, Cerletti C, de Gaetano G, Rotilio D. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 2008;19:43-50. (Pubitemid 351171556)
24. Zellner M, Winkler W, Hayden H, Diestinger M, Eliasen M, Gesslbauer B, Miller I, Chang M, Kungl A, Roth E, et al. Quantitative validation of different protein precipitation methods in proteome analysis of blood platelets. Electrophoresis 2005;26:2481-2489. (Pubitemid 40932756)
25. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000;21:1037-1053. (Pubitemid 30230771)
26. Benjamini Y, Hochberg YJ. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Royal Statist Soc B 1995;57:289-300.
27. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectro-metric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996;5:850-858.
28. Di Michele M, Marcone S, Cicchillitti L, Della Corte A, Ferlini C, Scambia G, Donati MB, Rotilio D. Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers. J Proteomics 2010;73:879-898.
29. Di Michele M, Della Corte A, Cicchillitti L, Del Boccio P, Urbani A, Ferlini C, Scambia G, Donati MB, Rotilio D. A proteomic approach to paclitaxe chemoresistance in ovarian cancer cell lines. Biochim Biophys Acta 2009;1794:225-236.
30. D'Imperio M, Della Corte A, Facchiano A, Di Michele M, Ferrandina G, Donati MB, Rotilio D. Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF. J Proteomics 2010; 73:1355-1367.
31. Maugeri N, Donati MB, de Gaetano G, Cerletti C. Formation of mixed platelet-PMN leukocyte aggregates in the platelet function analyzer (PFA-100) device. Thromb Haemost 2007; 97:156-157. (Pubitemid 46242399)
32. Hayward CP, Harrison P, Cattaneo M, Ortel TL, Rao AK. Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006;4:312-319.
33. Izzi B, Pampuch A, Costanzo S, Vohnout B, Iacoviello L, Cerletti C, de Gaetano G. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood. Thromb Haemost 2007;98:1276-1284. (Pubitemid 350239099)
34. Bereczky Z, Muszbek L. Factor XIII and venous thrombo-embolism. Semin Thromb Hemost 2011;37:305-314.
35. Serrano K, Devine DV. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation. Thromb Haemost 2002;88:315-320. (Pubitemid 34873715)
36. Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med 2002;252:130-139. (Pubitemid 34989274)
37. Magwenzi SG, Ajjan RA, Standeven KF, Parapia LA, Naseem KM. Factor XIII supports platelet activation and enhances thrombus formation by matrix proteins under flow conditions. J Thromb Haemost 2011;9:820-833.
38. Ariëns RA, Kohler HP, Mansfield MW, Grant PJ. Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension. Arterioscler Thromb Vasc Biol 1999; 19:2012-2016. (Pubitemid 29379937)
39. Muszbek L, Bereczky Z, Bagoly Z, Shemirani AH, Katona E. Factor XIII and atherothrombotic diseases. Semin Thromb Hemost 2010;36:18-33.
40. Barua RS, Sy F, Srikanth S, Huang G, Javed U, Buhari C, Margosan D, Ambrose JA. Effects of cigarette smoke exposure on clot dynamics and fibrin structure: An ex vivo investigation. Arterioscler Thromb Vasc Biol 2010;30:75-79.
41. Undas A, Topór-Madry R, Tracz W, Pasowicz M. Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis. Thromb Haemost 2009;102:1289-1291.
42. Iacoviello L, Bonanni A, Costanzo S, De Curtis A, Di Castelnuovo A, Olivieri M, Zito F, Donati MB, de Gaetano G. On behalf of the Moli-sani Project Investigators. The Moli-Sani Project, a randomized, prospective cohort study in the Molise region in Italy; design, rationale and objectives. Italian J Public Health 2007;4:110-118.
43. De Curtis A, Magnacca S, Marracino F, Costanzo S, Zito F, Di Castelnuovo A, Arcari A, Rago L, Di Giuseppe R, Persichillo M, et al. D-Dimer levels and risk factors for cardiovascular disease in a general adult Italian population: Results from the Moli-sani study. Haematologica 2008; 93(s3):16 (Abst C048).
44. Dardik R, Shenkman B, Tamarin I, Eskaraev R, Harsfalvi J, Varon D, Inbal A. Factor XIII mediates adhesion of platelets to endothelial cells through alpha(v)beta(3) and glycoprotein IIb/IIIa integrins. Thromb Res 2002;105:317-323. (Pubitemid 34621107)
45. Dardik R, Solomon A, Loscalzo J, Eskaraev R, Bialik A, Goldberg I, Schiby G, Inbal A. Novel proangiogenic effect of factor XIII associated with suppression of thrombospondin 1 expression. Arterioscler Thromb Vasc Biol 2003;23: 1472-1477. (Pubitemid 36994539)
46. White JG. Morphology and ultrastructure of platelets. In: Gresele P, Page CP, Fuster V, and Vermylen J, editors. Platelets in Thrombotic and Non-thrombotic Disorders. Cambridge: Cambridge University Press; 2002. pp 41-69.
47. Pieroni L, Finamore F, Ronci M, Mattoscio D, Marzano V, Mortera SL, Quattrucci S, Federici G, Romano M, Urbani A. Proteomics investigation of human platelets in healthy donors and cystic fibrosis patients by shotgun nUPLC-MSE and 2DE: A comparative study. Mol Biosyst 2011;7:630-639.
48. Kile BT, Panopoulos AD, Stirzaker RA, Hacking DF, Tahtamouni LH, Willson TA, Mielke LA, Henley KJ, Zhang JG, Wicks IP, et al. Mutations in the cofilin partner Aip1/Wdr1 cause autoinflammatory disease and macrothrom-bocytopenia. Blood 2007;110:2371-2380. (Pubitemid 47523157)
49. Joly AL, Wettstein G, Mignot G, Ghiringhelli F, Garrido C. Dual role of heat shock proteins as regulators of apoptosis and innate immunity. J Innate Immun 2010;2:238-247.
50. Polanowska-Grabowska R, Gear AR. Heat-shock proteins and platelet function. Platelets 2000;11:6-22. (Pubitemid 30201160)
51. Beere HM. Death versus survival: Functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 2005;115:2633-2639. (Pubitemid 41434386)
52. Jawa RS, Anillo S, Huntoon K, Baumann H, Kulaylat M. Analytic review: Interleukin-6 in surgery, trauma, and critical care: Part I: Basic science. J Intensive Care Med 2011;26: 3-12.
53. Gobert AP, Bambou JC, Werts C, Balloy V, Chignard M, Moran AP, Ferrero RL. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 2004;279:245-250. (Pubitemid 38044821)
54. Steele BM, Harper MT, Macaulay IC, Morrell CN, Perez-Tamayo A, Foy M, Habas R, Poole AW, Fitzgerald DJ, Maguire PB. Canonical Wnt signaling negatively regulates platelet function. Proc Natl Acad Sci USA 2009; 106:(1983)6-19841.